Clinical Endoscopy

Review

Korean guidelines for postpolypectomy colonoscopic surveillance: 2022 revised edition: Su Young Kim, Min Seob Kwak, Soon Man Yoon, Yunho Jung, Jong Wook Kim, Sun-Jin Boo, Eun Hye Oh, Seong Ran Jeon, Seung-Joo Nam, Seon-Young Park, Soo-Kyung Park, Jaeyoung Chun, Dong Hoon Baek, Mi-Young Choi, Suyeon Park, Jeong-Sik Byeon, Hyung Kil Kim, Joo Young Cho, Moon Sung Lee, Oh Young Lee, Korean Society of Gastrointestinal Endoscopy, Korean Society of Gastroenterology, Korean Association for the Study of Intestinal Diseases; Clin Endosc 2022;55(6):703-725. Published online October 13, 2022; DOI: https://doi.org/10.5946/ce.2022.136

Abstract PDF Supplementary Material PubReader ePub

Colonoscopic polypectomy is effective in decreasing the incidence and mortality of colorectal cancer (CRC). Premalignant polyps discovered during colonoscopy are associated with the risk of metachronous advanced neoplasia. Postpolypectomy surveillance is the most important method for the management of advanced metachronous neoplasia. A more efficient and evidence-based guideline for postpolypectomy surveillance is required because of limited medical resources and concerns regarding colonoscopy complications. In these consensus guidelines, an analytic approach was used to address all reliable evidence to interpret the predictors of CRC or advanced neoplasia during surveillance colonoscopy. The key recommendations state that the high-risk findings for metachronous CRC following polypectomy are as follows: (1) adenoma ≥10 mm in size; (2) 3 to 5 (or more) adenomas; (3) tubulovillous or villous adenoma; (4) adenoma containing high-grade dysplasia; (5) traditional serrated adenoma; (6) sessile serrated lesion (SSL) containing any grade of dysplasia; (7) serrated polyp of at least 10 mm in size; and (8) 3 to 5 (or more) SSLs. More studies are needed to fully comprehend the patients most likely to benefit from surveillance colonoscopy and the ideal surveillance interval to prevent metachronous CRC.

Citations

Citations to this article as recorded by

Association between Atherosclerosis and High-Risk Colorectal Adenomas based on Cardio-Ankle Vascular Index and Ankle-Brachial Index
Jung Ho Lee, Hyunseok Cho, Sang Hoon Lee, Sung Joon Lee, Chang Don Kang, Dae Hee Choi, Jin Myung Park, Seung-Joo Nam, Tae Suk Kim, Ji Hyun Kim, Sung Chul Park
The Korean Journal of Gastroenterology.2024; 83(4): 143. CrossRef
A survey of current practices in post-polypectomy surveillance in Korea
Jeongseok Kim, Tae-Geun Gweon, Min Seob Kwak, Su Young Kim, Seong Jung Kim, Hyun Gun Kim, Eun Ran Kim, Sung Noh Hong, Eun Sun Kim, Chang Mo Moon, Dae Seong Myung, Dong Hoon Baek, Shin Ju Oh, Hyun Jung Lee, Ji Young Lee, Yunho Jung, Jaeyoung Chun, Dong-Hoo
Intestinal Research.2024; 22(2): 186. CrossRef
Approaches and considerations in the endoscopic treatment of T1 colorectal cancer
Yunho Jung
The Korean Journal of Internal Medicine.2024; 39(4): 563. CrossRef
Utilizing ChatGPT4 in Deciding Follow-up Examination Intervals After Colonoscopy
Hyung-Hoon Oh
The Korean Journal of Gastroenterology.2024; 84(5): 239. CrossRef
Influence of Lifestyles on Polyp Burden and Cancer Development in Hereditary Colorectal Cancer Syndromes
Hye Kyung Hyun, Ji Soo Park, Jihye Park, Soo Jung Park, Jae Jun Park, Jae Hee Cheon, Tae Il Kim
Journal of Gastroenterology and Hepatology.2024;[Epub] CrossRef
Korean Guidelines for Postpolypectomy Colonoscopic Surveillance: 2022 Revision
Su Young Kim
The Korean Journal of Medicine.2023; 98(3): 102. CrossRef
Detecting colorectal lesions with image-enhanced endoscopy: an updated review from clinical trials
Mizuki Nagai, Sho Suzuki, Yohei Minato, Fumiaki Ishibashi, Kentaro Mochida, Ken Ohata, Tetsuo Morishita
Clinical Endoscopy.2023; 56(5): 553. CrossRef
Understanding colorectal polyps to prevent colorectal cancer
Dong-Hoon Yang
Journal of the Korean Medical Association.2023; 66(11): 626. CrossRef
Classification and endoscopic diagnosis of colorectal polyps
Ji Hyun Kim, Sung Chul Park
Journal of the Korean Medical Association.2023; 66(11): 633. CrossRef
Endoscopic treatment of colorectal polyps and early colorectal cancer
Yunho Jung
Journal of the Korean Medical Association.2023; 66(11): 642. CrossRef
Strategy for post-polypectomy colonoscopy surveillance: focus on the revised Korean guidelines
Yong Soo Kwon, Su Young Kim
Journal of the Korean Medical Association.2023; 66(11): 652. CrossRef

6,526 View
549 Download
10 Web of Science
11 Crossref

Original Article

A Nationwide Survey on the Facilities and Personnel for Endoscopic Sedation: Results from 50 Qualified Endoscopy Units of Teaching Hospitals Accredited by the Korean Society of Gastrointestinal Endoscopy (KSGE): Seon-Young Park, Jun Kyu Lee, Jung-Wook Kim, Tae Hee Lee, Chang-Hwan Park, Jae-Yong Jang, Byung-Wook Kim, Byung Ik Jang, the Quality management and Endoscopic sedation committee of Korean Society of Gastrointestinal Endoscopy (KSGE); Clin Endosc 2021;54(6):843-850. Published online July 14, 2021; DOI: https://doi.org/10.5946/ce.2021.014

Abstract PDF Supplementary Material PubReader ePub

Background
/Aims: This study aimed to determine the current status of facilities, equipment, and personnel for endoscopic sedation from endoscopy units of representative hospitals in South Korea.
Methods
A questionnaire survey was conducted on 50 qualified endoscopy units accredited by the Korean Society of Gastrointestinal Endoscopy.
Results
All included endoscopy units had regulations and educational programs regarding sedation training for endoscopists and nursing personnel. There present one assisting nurse during endoscopy in 35 units (70%) and at least two nurses in 12 units (24.0%). All endoscopy units had examination rooms equipped with oxygen supply and suction systems. Endoscopist-directed sedation was performed in 48 units (96.0%). Propofol-based sedation was the most used sedation method. All units had a separate recovery bay. The daily number of patients per bed was greater than 10 in 17 units (34.0%). In 26 (52.0%) units, a single nurse cared for ≥10 patients per day. All the units fulfilled the discharge criteria.
Conclusions
This study presents data regarding endoscopic sedation clinical practice in 50 endoscopy units in South Korea. This study presents the current status of endoscopic sedation clinical practice in 50 qualified endoscopy units accredited by the KSGE, which provide excellent quality management.

Citations

Citations to this article as recorded by

Awareness of Endoscopy Nurses About Anesthesia Management in the Pediatric Gastrointestinal Endoscopy Unit; A Survey Study
Feyza SEVER, Şamil HIZLI
Turkish Journal of Pediatric Disease.2023; : 412. CrossRef
Drugs used for sedation in gastrointestinal endoscopy
Jun Kyu Lee
Journal of the Korean Medical Association.2022; 65(11): 735. CrossRef

4,022 View
127 Download
2 Web of Science
2 Crossref

Focused Review Series: Future Perspectives of Fecal Microbiota Transplatation

Fecal Microbiota Transplantation: Is It Safe?: Seon-Young Park, Geom Seog Seo; Clin Endosc 2021;54(2):157-160. Published online March 30, 2021; DOI: https://doi.org/10.5946/ce.2021.072

Abstract PDF PubReader ePub

Fecal microbiota transplantation (FMT) is an accepted procedure for the management of recurrent Clostridioides difficile infections. FMT is generally considered safe and well-tolerated - even in high-risk patients. Most short-term risks are mild and known to be associated with delivery methods. Long-term side effects have not been established, and no signs of harm have been found to date. However, causality for several microbiome-associated diseases has to be established. Even though FMT is generally considered safe with strict donor screening, serious adverse events have been recently associated with the FMT product from the stool bank, where screening for multi-drug resistant organisms is not included in protocols. Here, we discuss the adverse events associated with FMT and safety issues.

Citations

Citations to this article as recorded by

Fecal microbiota transplantation, a tool to transfer healthy longevity
Marta G. Novelle, Beatriz Naranjo-Martínez, Juan L. López-Cánovas, Alberto Díaz-Ruiz
Ageing Research Reviews.2025; 103: 102585. CrossRef
The gut-reproductive axis: Bridging microbiota balances to reproductive health and fetal development
Bohao Li, Yan Xiong, Dong Guo, Guohong Deng, Haibo Wu
International Immunopharmacology.2025; 144: 113627. CrossRef
“Bridging Microbiomes: Exploring Oral and Gut Microbiomes in Autoimmune Thyroid Diseases- New Insights and Therapeutic Frontiers
Daliya Abubakar, Hala Abdullahi, Ibrahim Ibrahim
Gut Microbes Reports.2025; : 1. CrossRef
Probiotics as adjuvants to mitigate adverse reactions and enhance effectiveness in Food Allergy Immunotherapy
Ingrid Lamminpää, Elena Niccolai, Amedeo Amedei
Scandinavian Journal of Immunology.2024;[Epub] CrossRef
ADS024, a single-strain live biotherapeutic product of Bacillus velezensis alleviates dextran sulfate-mediated colitis in mice, protects human colonic epithelial cells against apoptosis, and maintains epithelial barrier function
Sophie Irwin, Andrea Chupina Estrada, Becca Nelson, Ashlen Bullock, Berkeley Limketkai, Wendy Ho, Susan Acton, Laurent Chesnel, Hon Wai Koon
Frontiers in Microbiology.2024;[Epub] CrossRef
Metabolic model predictions enable targeted microbiome manipulation through precision prebiotics
Georgios Marinos, Inga K. Hamerich, Reena Debray, Nancy Obeng, Carola Petersen, Jan Taubenheim, Johannes Zimmermann, Dana Blackburn, Buck S. Samuel, Katja Dierking, Andre Franke, Matthias Laudes, Silvio Waschina, Hinrich Schulenburg, Christoph Kaleta, Pau
Microbiology Spectrum.2024;[Epub] CrossRef
Protective effects of fecal microbiota transplantation against ischemic stroke and other neurological disorders: an update
Tousif Ahmed Hediyal, C. Vichitra, Nikhilesh Anand, Mahendran Bhaskaran, Saeefh M. Essa, Pravir Kumar, M. Walid Qoronfleh, Mohammed Akbar, Ruchika Kaul-Ghanekar, Arehally M. Mahalakshmi, Jian Yang, Byoung-Joon Song, Tanya M. Monaghan, Meena Kishore Sakhar
Frontiers in Immunology.2024;[Epub] CrossRef
Past, present, and future of microbiome-based therapies
Pilar Manrique, Ignacio Montero, Marta Fernandez-Gosende, Noelia Martinez, Claudio Hidalgo Cantabrana, David Rios-Covian
Microbiome Research Reports.2024;[Epub] CrossRef
Changes in the Progression of Chronic Kidney Disease in Patients Undergoing Fecal Microbiota Transplantation
Giovanna Yazmín Arteaga-Muller, Samantha Flores-Treviño, Paola Bocanegra-Ibarias, Diana Robles-Espino, Elvira Garza-González, Graciela Catalina Fabela-Valdez, Adrián Camacho-Ortiz
Nutrients.2024; 16(8): 1109. CrossRef
The Importance of Microbiota and Fecal Microbiota Transplantation in Pancreatic Disorders
Adrian Boicean, Cristian Ichim, Samuel Bogdan Todor, Paula Anderco, Mirela Livia Popa
Diagnostics.2024; 14(9): 861. CrossRef
Can fecal microbiota transplantations modulate autoimmune responses in type 1 diabetes?
Coco M. Fuhri Snethlage, Douwe de Wit, Koen Wortelboer, Elena Rampanelli, Nordin M. J. Hanssen, Max Nieuwdorp
Immunological Reviews.2024; 325(1): 46. CrossRef
Friend or Foe: Exploring the Relationship between the Gut Microbiota and the Pathogenesis and Treatment of Digestive Cancers
Monica Profir, Oana Roşu, Sanda Creţoiu, Bogdan Gaspar
Microorganisms.2024; 12(5): 955. CrossRef
The gut microbiota patterns of patients with COVID-19: protocol for a case-control study
Seyed Aria Nejadghaderi, Ehsan Nazemalhosseini-Mojarad, Asra Fazlollahi, Ali Pirsadeghi, Ainaz Khalili, Rasoul Ebrahimi, Nima Rezaei
Translational Medicine Communications.2024;[Epub] CrossRef
Fecal microbiota transplantation and next-generation therapies: A review on targeting dysbiosis in metabolic disorders and beyond
Zenawork Sahle, Getabalew Engidaye, Demissew Shenkute Gebreyes, Behailu Adenew, Tsegahun Asfaw Abebe
SAGE Open Medicine.2024;[Epub] CrossRef
Fecal microbiota transplantation: A potential novel treatment strategy for extensively drug-resistant tuberculosis
Seyed Aria Nejadghaderi, Alexander L. Chu
Medical Hypotheses.2024; 189: 111396. CrossRef
Potential of Synbiotics and Probiotics as Chemopreventive Agent
Kah Wei Chin, Shing Ching Khoo, Richard Paul Merisha Paul, Vijitra Luang-In, Su Datt Lam, Nyuk Ling Ma
Probiotics and Antimicrobial Proteins.2024; 16(6): 2085. CrossRef
Gut-derived immune cells and the gut-lung axis in ARDS
Mairi Ziaka, Aristomenis Exadaktylos
Critical Care.2024;[Epub] CrossRef
Assessing the Therapeutic Potential of Fecal Microbiota Transplantation in Steatotic Liver Disease: Current Insights and Future Pathways
Carolina Jiménez-González, Ignacio Vallejo, David Sordo, Juan Manuel Medina-Méndez, Marta Alonso-Peña, Javier Crespo
Current Hepatology Reports.2024; 23(4): 435. CrossRef
Extracellular Vesicles from Nanomedicine‐Trained Intestinal Microbiota Substitute for Fecal Microbiota Transplant in Treating Ulcerative Colitis
Menghang Zu, Ga Liu, Haiting Xu, Zhenhua Zhu, Junfeng Zhen, Baoyi Li, Xiaoxiao Shi, Mohammad‐Ali Shahbazi, Rui L. Reis, Subhas C. Kundu, Guangjun Nie, Bo Xiao
Advanced Materials.2024;[Epub] CrossRef
Clinical application of live biotherapeutic products in infectious diseases
Bhagyashri D. Navalkele, Teena Chopra
Frontiers in Microbiomes.2024;[Epub] CrossRef
The Impact of Infections in Patients Treated with Atezolizumab Plus Bevacizumab for Unresectable Hepatocellular Carcinoma
Abdullah Esmail, Jiaqiong Xu, Ethan A. Burns, Karen Abboud, Ali Sheikh, Godsfavour Umoru, Kelly Gee, Catherine Wiechmann, Yuqi Zhang, Maen Abdelrahim
Journal of Clinical Medicine.2024; 13(17): 4994. CrossRef
Faecal microbiota transplantation associated adverse events
Rafal Patryn, Natalia Kazmierczak-Wojtas, Lucyna Bulas, Olga Boretska, Monika Szkultecka-Debek, Mariola Drozd, Tomasz Blicharski
Current Issues in Pharmacy and Medical Sciences.2024; 37(3): 171. CrossRef
Gut microbe–host interactions in post-COVID syndrome: a debilitating or restorative partnership?
Torsten P. M. Scheithauer, Roy C. Montijn, Arnout Mieremet
Gut Microbes.2024;[Epub] CrossRef
Safety and efficacy of fecal microbiota transplantation (FMT) as a modern adjuvant therapy in various diseases and disorders: a comprehensive literature review
Mehdi Karimi, Niyousha Shirsalimi, Zahra Hashempour, Hossein Salehi Omran, Eshagh Sedighi, Farzan Beigi, Masoud Mortezazadeh
Frontiers in Immunology.2024;[Epub] CrossRef
Refractory Crohn’s Disease: Perspectives, Unmet Needs and Innovations
Luisa Bertin, Martina Crepaldi, Miriana Zanconato, Greta Lorenzon, Daria Maniero, Caterina De Barba, Erica Bonazzi, Sonia Facchin, Marco Scarpa, Cesare Ruffolo, Imerio Angriman, Andrea Buda, Fabiana Zingone, Edoardo Vincenzo Savarino, Brigida Barberio
Clinical and Experimental Gastroenterology.2024; Volume 17: 261. CrossRef
Exploring the Frontier: The Human Microbiome’s Role in Rare Childhood Neurological Diseases and Epilepsy
Newell Belnap, Keri Ramsey, Sophia T. Carvalho, Lexi Nearman, Hannah Haas, Matt Huentelman, Keehoon Lee
Brain Sciences.2024; 14(11): 1051. CrossRef
Gut Microbiota and New Microbiome-Targeted Drugs for Clostridioides difficile Infections
Ahran Lee, Jung Sik Yoo, Eun-Jeong Yoon
Antibiotics.2024; 13(10): 995. CrossRef
Fecal Microbiota Transplantation: Insights into Colon Carcinogenesis and Immune Regulation
Olga Brusnic, Danusia Onisor, Adrian Boicean, Adrian Hasegan, Cristian Ichim, Andreea Guzun, Radu Chicea, Samuel Bogdan Todor, Bogdan Ioan Vintila, Paula Anderco, Corina Porr, Horatiu Dura, Sorin Radu Fleaca, Adrian Nicolae Cristian
Journal of Clinical Medicine.2024; 13(21): 6578. CrossRef
Gut Microbiota and Immune System Dynamics in Parkinson’s and Alzheimer’s Diseases
Natasa Kustrimovic, Sahar Balkhi, Giorgia Bilato, Lorenzo Mortara
International Journal of Molecular Sciences.2024; 25(22): 12164. CrossRef
Fecal microbiota transplantation for glaucoma; a potential emerging treatment strategy
Rasoul Ebrahimi, Yeganeh Farsi, Seyed Aria Nejadghaderi
Current Research in Microbial Sciences.2024; 7: 100314. CrossRef
Health Benefits of Prebiotics, Probiotics, Synbiotics, and Postbiotics
Nasser Al-Habsi, Maha Al-Khalili, Syed Ariful Haque, Moussa Elias, Nada Al Olqi, Tasnim Al Uraimi
Nutrients.2024; 16(22): 3955. CrossRef
The Microbiome–Genetics Axis in Autism Spectrum Disorders: A Probiotic Perspective
Marija Mihailovich, Maja Tolinački, Svetlana Soković Bajić, Sanja Lestarevic, Milica Pejovic-Milovancevic, Nataša Golić
International Journal of Molecular Sciences.2024; 25(22): 12407. CrossRef
More than just a number: the gut microbiota and brain function across the extremes of life
Nathan D. Nuzum, Clara Deady, Sarah Kittel-Schneider, John F. Cryan, Siobhain M. O'Mahony, Gerard Clarke
Gut Microbes.2024;[Epub] CrossRef
Metabolites in the Dance: Deciphering Gut-Microbiota-Mediated Metabolic Reprogramming of the Breast Tumor Microenvironment
Afaf Altrawy, Maye M. Khalifa, Asmaa Abdelmaksoud, Yomna Khaled, Zeinab M. Saleh, Hager Sobhy, Shaimaa Abdel-Ghany, Amany Alqosaibi, Afnan Al-Muhanna, Jawaher Almulhim, Ahmed El-Hashash, Hussein Sabit, Borros Arneth
Cancers.2024; 16(24): 4132. CrossRef
Gut Microbiota-Targeted Interventions in the Management of Chronic Kidney Disease
Keiichi Sumida, Joseph F. Pierre, Melana Yuzefpolskaya, Paolo C. Colombo, Ryan T. Demmer, Csaba P. Kovesdy
Seminars in Nephrology.2023; 43(2): 151408. CrossRef
Fecal microbiota transplantation in childhood: past, present, and future
Xu Gu, Zhao-Hong Chen, Shu-Cheng Zhang
World Journal of Pediatrics.2023; 19(9): 813. CrossRef
Bacteria-driven bio-therapy: From fundamental studies to clinical trials
Yuxuan Yu, Sicen Lin, Zhichao Chen, Bin Qin, Zhonggui He, Maosheng Cheng, Mengchi Sun, Jin Sun
Nano Today.2023; 48: 101731. CrossRef
Role of microbial dysbiosis in the pathogenesis of Alzheimer's disease
Gudimetla Susmitha, Rahul Kumar
Neuropharmacology.2023; 229: 109478. CrossRef
Non-Toxigenic Clostridioides difficile Strain E4 (NTCD-E4) Prevents Establishment of Primary C. difficile Infection by Epidemic PCR Ribotype 027 in an In Vitro Human Gut Model
Perezimor Etifa, César Rodríguez, Céline Harmanus, Ingrid M. J. G. Sanders, Igor A. Sidorov, Olufunmilayo A. Mohammed, Emily Savage, Andrew R. Timms, Jane Freeman, Wiep Klaas Smits, Mark H. Wilcox, Simon D. Baines
Antibiotics.2023; 12(3): 435. CrossRef
Discovery of Lactomodulin, a Unique Microbiome-Derived Peptide That Exhibits Dual Anti-Inflammatory and Antimicrobial Activity against Multidrug-Resistant Pathogens
Walaa K. Mousa, Rose Ghemrawi, Tareq Abu-Izneid, Azza Ramadan, Farah Al-Marzooq
International Journal of Molecular Sciences.2023; 24(8): 6901. CrossRef
The Influence of Gut Microbial Species on Diabetes Mellitus
Raghad Khalid AL-Ishaq, Samson Mathews Samuel, Dietrich Büsselberg
International Journal of Molecular Sciences.2023; 24(9): 8118. CrossRef
Neurodegenerative and Neurodevelopmental Diseases and the Gut-Brain Axis: The Potential of Therapeutic Targeting of the Microbiome
Brian Bicknell, Ann Liebert, Thomas Borody, Geoffrey Herkes, Craig McLachlan, Hosen Kiat
International Journal of Molecular Sciences.2023; 24(11): 9577. CrossRef
Gut Microbiome Transplants and Their Health Impacts across Species
Benjamin H. Levine, Jessica M. Hoffman
Microorganisms.2023; 11(6): 1488. CrossRef
Gut microbiota changes associated with Clostridioides difficile infection and its various treatment strategies
Anne J. Gonzales-Luna, Travis J. Carlson, Kevin W. Garey
Gut Microbes.2023;[Epub] CrossRef
The Role of Gut Dysbiosis in the Loss of Intestinal Immune Cell Functions and Viral Pathogenesis
Farzaneh Fakharian, Siva Thirugnanam, David A. Welsh, Woong-Ki Kim, Jay Rappaport, Kyle Bittinger, Namita Rout
Microorganisms.2023; 11(7): 1849. CrossRef
Swiss expert opinion: current approaches in faecal microbiota transplantation in daily practice
Laura Rossier, Christoph Matter, Emanuel Burri, Tatiana Galperine, Petr Hrúz, Pascal Juillerat, Alain Schoepfer, Stephan R. Vavricka, Nadine Zahnd, Natalie Décosterd, Frank Seibold
Swiss Medical Weekly.2023; 153(8): 40100. CrossRef
Non-alcoholic fatty liver disease and gut microbial dysbiosis- underlying mechanisms and gut microbiota mediated treatment strategies
Muthukumaran Jayachandran, Shen Qu
Reviews in Endocrine and Metabolic Disorders.2023; 24(6): 1189. CrossRef
Fecal Microbiota Transplantation in Liver Cirrhosis
Adrian Boicean, Victoria Birlutiu, Cristian Ichim, Olga Brusnic, Danusia Maria Onișor
Biomedicines.2023; 11(11): 2930. CrossRef
Fecal Microbiota Transplantation in Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Parnian Jamshidi, Yeganeh Farsi, Zahra Nariman, Mohammad Reza Hatamnejad, Benyamin Mohammadzadeh, Hossein Akbarialiabad, Mohammad Javad Nasiri, Leonardo A. Sechi
International Journal of Molecular Sciences.2023; 24(19): 14562. CrossRef
Gut microbiota of Suncus murinus, a naturally obesity-resistant animal, improves the ecological diversity of the gut microbiota in high-fat-diet-induced obese mice
Mingshou Zhang, Ting Yang, Rujia Li, Ke Ren, Jun Li, Maozhang He, Juefei Chen, Shuang-Qin Yi, Farah Al-Marzooq
PLOS ONE.2023; 18(11): e0293213. CrossRef
New Awareness of the Interplay Between the Gut Microbiota and Circadian Rhythms
Xiaoxiao Pang, Long Chen, Guoxin Xu
Polish Journal of Microbiology.2023; 72(4): 355. CrossRef
Clinical Practice Guidelines for Fecal Microbiota Transplantation in Korea
Tae-Geun Gweon, Yoo Jin Lee, Kyeong Ok Kim, Sung Kyun Yim, Jae Seung Soh, Seung Young Kim, Jae Jun Park, Seung Yong Shin, Tae Hee Lee, Chang Hwan Choi, Young-Seok Cho, Dongeun Yong, Jin-Won Chung, Kwang Jae Lee, Oh Young Lee, Myung-Gyu Choi, Miyoung Choi
Journal of Neurogastroenterology and Motility.2022; 28(1): 28. CrossRef
A Potential Synbiotic Strategy for the Prevention of Type 2 Diabetes: Lactobacillus paracasei JY062 and Exopolysaccharide Isolated from Lactobacillus plantarum JY039
Jiayuan Zhao, Lihan Wang, Shasha Cheng, Yu Zhang, Mo Yang, Ruxue Fang, Hongxuan Li, Chaoxin Man, Yujun Jiang
Nutrients.2022; 14(2): 377. CrossRef
Linking circadian rhythms to microbiome-gut-brain axis in aging-associated neurodegenerative diseases
Wai-Yin Cheng, Yuen-Shan Ho, Raymond Chuen-Chung Chang
Ageing Research Reviews.2022; 78: 101620. CrossRef
Modulating the Gut Microbiota as a Therapeutic Intervention for Alzheimer’s Disease
Mingli Liu, Ping Zhong
Indian Journal of Microbiology.2022; 62(4): 494. CrossRef
Role of Microbiota in Viral Infections and Pathological Progression
Taketoshi Mizutani, Aya Ishizaka, Michiko Koga, Takeya Tsutsumi, Hiroshi Yotsuyanagi
Viruses.2022; 14(5): 950. CrossRef
Current Trends and Challenges of Fecal Microbiota Transplantation—An Easy Method That Works for All?
Cátia Almeida, Rita Oliveira, Pilar Baylina, Rúben Fernandes, Fábio G. Teixeira, Pedro Barata
Biomedicines.2022; 10(11): 2742. CrossRef
Consortium of Indigenous Fecal Bacteria in the Treatment of Metabolic Syndrome
Elena Ermolenko, Marina Kotyleva, Anna Kotrova, Sergey Tichonov, Nadezhda Lavrenova, Lyubov Voropaeva, Yulia Topalova, Alena Karaseva, Daniil Azarov, Konstantin Ermolenko, Dmitrii Druzhininskii, Alexander Dmitriev, Alexander Shishkin, Alexander Suvorov
Microorganisms.2022; 10(8): 1574. CrossRef
Machine learning on the road to unlocking microbiota’s potential for boosting immune checkpoint therapy
Szymon Wojciechowski, Monika Majchrzak-Górecka, Paweł Biernat, Krzysztof Odrzywołek, Łukasz Pruss, Konrad Zych, Jan Majta, Kaja Milanowska-Zabel
International Journal of Medical Microbiology.2022; 312(7): 151560. CrossRef
Exploring the Connection Between the Gut Microbiome and Parkinson’s Disease Symptom Progression and Pathology: Implications for Supplementary Treatment Options
Dennis G. Chan, Katelyn Ventura, Ally Villeneuve, Paul Du Bois, Matthew R. Holahan
Journal of Parkinson's Disease.2022; 12(8): 2339. CrossRef
Microbiome Therapeutics for Food Allergy
Diana A. Chernikova, Matthew Y. Zhao, Jonathan P. Jacobs
Nutrients.2022; 14(23): 5155. CrossRef
From fecal microbiota transplantation toward next-generation beneficial microbes: The case of Anaerobutyricum soehngenii
Koen Wortelboer, Annefleur M. Koopen, Hilde Herrema, Willem M. de Vos, Max Nieuwdorp, E. Marleen Kemper
Frontiers in Medicine.2022;[Epub] CrossRef
Foods may modify responsiveness to cancer immune checkpoint blockers by altering both the gut microbiota and activation of estrogen receptors in immune cells
Leena Hilakivi-Clarke, Vivek Verma, Maddie McDermott, Pal Koak, Fabia de Oliveira Andrade
Frontiers in Microbiomes.2022;[Epub] CrossRef
La microbiota intestinal en la salud y en la enfermedad
M.Á. Ortega, C. García-Montero, O. Fraile-Martínez, J. Monserrat, M.A. Álvarez-Mon
Medicine - Programa de Formación Médica Continuada Acreditado.2022; 13(69): 4054. CrossRef

5,680 View
157 Download
60 Web of Science
64 Crossref

Original Article

Predictors of Rebleeding in Upper Gastrointestinal Dieulafoy Lesions: Sang-Hun Park, Du-Hyeon Lee, Chang-Hwan Park, Jin Jeon, Ho-Jun Lee, Sung-Uk Lim, Seon-Young Park, Hyun-Soo Kim, Sung-Kyu Choi, Jong-Sun Rew; Clin Endosc 2015;48(5):385-391. Published online September 30, 2015; DOI: https://doi.org/10.5946/ce.2015.48.5.385

Abstract PDF PubReader ePub

Background/Aims

Dieulafoy lesions (DLs) are a rare but significant cause of upper gastrointestinal bleeding. We aimed to define the clinical significance of rebleeding and identify the predictors of rebleeding and mortality in upper gastrointestinal Dieulafoy lesions (UGIDLs).

Methods

Patients diagnosed with UGIDLs between January 2004 and June 2013 were retrospectively evaluated. Multivariate logistic regression analyses were performed to define the predictors of rebleeding and mortality in patients with UGIDLs.

Results

The study group consisted of 81 male and 36 female patients. Primary hemostasis was achieved in 115 out of 117 patients (98.3%) with various endoscopic therapies. Rebleeding occurred in 10 patients (8.5%). The mortality rate was significantly higher in patients with rebleeding than in those without rebleeding (30.0% vs. 4.7%, p=0.020). Multivariate logistic regression analysis revealed that kidney disease (p=0.006) and infection (p=0.005) were significant predictors of rebleeding in UGIDLs and that kidney disease (p=0.004) and platelet count (p=0.013) were significant predictors of mortality.

Conclusions

Rebleeding has an important prognostic significance in patients with UGIDLs. Kidney disease and infection are major predictors of rebleeding and mortality in patients with UGIDLs.

Citations

Citations to this article as recorded by

Clinical outcomes of Dieulafoy's lesion compared with peptic ulcer in upper gastrointestinal bleeding
Sang Yong Jo, Jin Hee Noh, Boram Cha, Ji Yong Ahn, Seung‐pyo Oh, Jun‐young Seo, Hee Kyong Na, Jeong Hoon Lee, Kee Wook Jung, Do Hoon Kim, Kee Don Choi, Ho June Song, Gin Hyug Lee, Hwoon‐Yong Jung
Journal of Gastroenterology and Hepatology.2023; 38(6): 888. CrossRef
Intragastric Single-Port Surgery: An Innovative and Multipurpose Technique for the Therapy of Upper Digestive Tract Lesions
Renjie Li, Wilfried Veltzke-Schlieker, Andreas Adler, Mahmoud Ismail, Harun Badakhshi, Ricardo Zorron
Surgical Innovation.2022; 29(1): 56. CrossRef
Outcomes in Severe Upper GI Hemorrhage from Dieulafoy’s Lesion with Monitoring of Arterial Blood Flow
B. Nulsen, D. M. Jensen, T. O. G. Kovacs, K. A. Ghassemi, M. Kaneshiro, G. S. Dulai, R. Jutabha, J. A. Gornbein
Digestive Diseases and Sciences.2021; 66(10): 3495. CrossRef
Hybrid surgical technologies in the treatment of patients with Dieulafoy’s lesion complicated by recurrent gastrointestinal bleeding
S.E. Voskanyan, M.V. Shabalin, A.I. Artemyev, I.Yu. Kolyshev, Z. Bogoevich, A.N. Bashkov, E.V. Naidenov
Endoskopicheskaya khirurgiya.2020; 26(1): 40. CrossRef
Dieulafoy Lesion: Predictive Factors of Early Relapse and Long-Term Follow-Up
Paulo Massinha, Inês Cunha, Luís Tomé
GE - Portuguese Journal of Gastroenterology.2020; 27(4): 237. CrossRef
A Rare Cause of Gastrointestinal Bleeding in a 65-Year-Old Man with History of Polycythemia Vera
Najmeh Aletaha, Hoda Hamid, Niloofar Ayoobi Yazdi, Reza Taslimi, Bijan Shahbazkhani, Pardis Ketabi Moghadam
Middle East Journal of Digestive Diseases.2019; 11(4): 225. CrossRef
Lesión de Dieulafoy en estómago como causa de sangrado gastrointestinal alto: presentación de un caso
Jairo Alonso Sierra-Avendaño, Fabián Andrés Mejía-Casadiegos, María Paula Pérez-Barón, Gabriel Eduardo Pérez-García
Revista Médicas UIS.2019; 32(1): 27. CrossRef
Endoscopic Management of Nonvariceal, Nonulcer Upper Gastrointestinal Bleeding
Michael A. Chang, Thomas J. Savides
Gastrointestinal Endoscopy Clinics of North America.2018; 28(3): 291. CrossRef
Refractory Gastric Hemorrhage from Caliber Persistent Arteries of the Left Inferior Phrenic Artery
Takahiro Hosoi, Norihiro Yuasa, Eiji Takeuchi, Hideo Miyake, Hidemasa Nagai, Yuichiro Yoshioka, Masataka Okuno, Takayuki Minami, Kanji Miyata, Masahiko Fujino
The Japanese Journal of Gastroenterological Surgery.2017; 50(2): 112. CrossRef

6,754 View
87 Download
5 Web of Science
9 Crossref

Case Report

Eosinophilic Gastroenteritis Due to Rhus Ingestion Presenting with Gastrointestinal Hemorrhage: Wonsuk Choi, Seon-Young Park, Chan Choi, Kyuman Cho, Chang-Hwan Park, Hyun-Soo Kim, Sung-Kyu Choi, Jong-Sun Rew; Clin Endosc 2015;48(2):174-177. Published online March 27, 2015; DOI: https://doi.org/10.5946/ce.2015.48.2.174

Abstract PDF PubReader ePub

Rhus-related illnesses in Korea are mostly caused by ingestion of parts of the Rhus tree. Contact dermatitis occurrence after ingestion of Rhus-related food is very common in Korea. However, Rhus-related gastrointestinal disease is very rare. Herein, we present a case of eosinophilic gastroenteritis caused by Rhus ingestion. A 75-year-old woman was admitted with hematemesis and hematochezia after Rhus extract ingestion. Routine laboratory tests revealed leukocytosis without eosinophilia. Endoscopy showed friable and granular mucosal changes with touch bleeding in the second portion of the duodenum. Abdominal computed tomography revealed edematous wall thickening of the duodenum and proximal jejunal loops. Patch testing with Rhus extracts showed a strong positive reaction, suggesting Rhus as the allergen. Her symptoms improved after avoidance of the allergen.

Citations

Citations to this article as recorded by

Systemic contact dermatitis induced by Rhus allergens in Korea: exercising caution in the consumption of this nutritious food
S. J. Park, J. W. Park, K. Y. Park, K. Li, S. J. Seo, B. J. Kim, K. H. Yoo
Clinical and Experimental Dermatology.2021; 46(2): 324. CrossRef
Upper Gastrointestinal Bleeding as the First Presentation of Eosinophilic Gastrointestinal Disease
Elif Ozdogan, Latife Doganay Caglayan, Ozlem Mizikoglu, Cigdem Arikan
JPGN Reports.2020; 1(2): e017. CrossRef
Severe upper gastrointestinal bleeding due to eosinophilic gastritis
Valentín Gonzalez-Canalizo, Nerea Segues, Andrea Medina, Silvia Torrente, Vanessa Aguilar-Gama, Paula Ortega, Luis Bujanda
Gastroenterología y Hepatología.2019; 42(5): 307. CrossRef
Severe upper gastrointestinal bleeding due to eosinophilic gastritis
Valentín Gonzalez-Canalizo, Nerea Segues, Andrea Medina, Silvia Torrente, Vanessa Aguilar-Gama, Paula Ortega, Luis Bujanda
Gastroenterología y Hepatología (English Edition).2019; 42(5): 307. CrossRef

9,116 View
87 Download
3 Web of Science
4 Crossref

First
Prev
Page of 1
Next
Last

Search